Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 26,645 | 18,408 | 8,237 | 0 |
| Operating Income | -26,645 | -18,408 | -8,237 | N/A |
| Interest Expense | 0 | 174 | 3,342 | 0 |
| Other Income | 577 | -2,087 | -1,307 | 0 |
| Pre-tax Income | -26,068 | -20,669 | -12,886 | 0 |
| Income Tax | -18 | -124 | -26 | N/A |
| Net Income Continuous | -26,050 | -20,545 | -12,860 | N/A |
| Net Income | $-26,050 | $-20,545 | $-12,860 | $N/A |
| EPS Basic Total Ops | -2.28 | -58.44 | -29.80 | N/A |
| EPS Basic Continuous Ops | -2.22 | -46.91 | -30.55 | N/A |
| EPS Diluted Total Ops | -2.28 | -58.44 | -29.80 | N/A |
| EPS Diluted Continuous Ops | -2.22 | -46.91 | -30.55 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.28 | N/A | N/A | N/A |
| EBITDA(a) | $-26,606 | $-18,325 | $-6,052 | $N/A |